| GILD |
Gilead Sciences, Inc. |
115.85B |
8.72% |
|
|
|
|
|
92.96 |
1.22% |
24.35% |
38.35% |
|---|
| AMGN |
Amgen Inc. |
147.72B |
7.97% |
|
|
|
|
|
274.81 |
0.99% |
27.86% |
24.94% |
|---|
| REGN |
Regeneron Pharmaceuticals, Inc. |
74.33B |
7.63% |
|
|
|
|
|
687.80 |
0.91% |
35.86% |
61.72% |
|---|
| VRTX |
Vertex Pharmaceuticals Incorporated |
110.19B |
7.49% |
|
|
|
|
|
427.89 |
1.40% |
30.04% |
34.00% |
|---|
| AZN |
AstraZeneca PLC |
210.75B |
3.83% |
|
|
|
|
|
67.96 |
2.04% |
29.19% |
69.45% |
|---|
| ALNY |
Alnylam Pharmaceuticals, Inc. |
34.18B |
3.04% |
|
|
|
|
|
264.99 |
7.60% |
33.02% |
21.33% |
|---|
| BIIB |
Biogen Inc. |
20.54B |
2.19% |
|
|
|
|
|
140.98 |
0.31% |
37.19% |
62.53% |
|---|
| ILMN |
Illumina, Inc. |
22.41B |
2.13% |
|
|
|
|
|
141.31 |
3.40% |
39.88% |
20.68% |
|---|
| ARGX |
argenx SE |
39.08B |
2.00% |
|
|
|
|
|
647.39 |
1.07% |
34.52% |
12.76% |
|---|
| UTHR |
United Therapeutics Corporation |
16.43B |
1.59% |
|
|
|
|
|
367.97 |
2.52% |
31.02% |
56.75% |
|---|
| MRNA |
Moderna, Inc. |
13.81B |
1.53% |
|
|
|
|
|
35.89 |
5.37% |
69.63% |
55.08% |
|---|
| VTRS |
Viatris Inc. |
13.52B |
1.48% |
|
|
|
|
|
11.33 |
0.27% |
27.64% |
37.90% |
|---|
| SNY |
Sanofi |
129.00B |
1.46% |
|
|
|
|
|
51.69 |
1.87% |
26.63% |
50.32% |
|---|
| NBIX |
Neurocrine Biosciences, Inc. |
14.77B |
1.40% |
|
|
|
|
|
145.88 |
1.83% |
39.33% |
38.71% |
|---|
| SMMT |
Summit Therapeutics Inc. |
16.29B |
1.33% |
|
|
|
|
|
22.10 |
16.13% |
62.39% |
11.60% |
|---|
| INCY |
Incyte Corporation |
14.15B |
1.32% |
|
|
|
|
|
73.47 |
2.14% |
49.14% |
59.28% |
|---|
| BMRN |
BioMarin Pharmaceutical Inc. |
11.92B |
1.26% |
|
|
|
|
|
62.53 |
1.63% |
30.53% |
24.93% |
|---|
| INSM |
Insmed Incorporated |
13.73B |
1.24% |
|
|
|
|
|
76.75 |
5.85% |
45.20% |
5.57% |
|---|
| SRPT |
Sarepta Therapeutics, Inc. |
11.16B |
1.15% |
|
|
|
|
|
116.79 |
-1.03% |
34.27% |
-1.41% |
|---|
| RPRX |
Royalty Pharma plc |
13.46B |
1.13% |
|
|
|
|
|
30.30 |
-1.46% |
26.06% |
13.15% |
|---|
| BNTX |
BioNTech SE |
28.11B |
1.11% |
|
|
|
|
|
117.25 |
4.75% |
40.64% |
39.77% |
|---|
| MEDP |
Medpace Holdings, Inc. |
10.80B |
1.05% |
|
|
|
|
|
347.52 |
3.01% |
55.02% |
55.11% |
|---|
| PCVX |
Vaxcyte, Inc. |
10.99B |
1.00% |
|
|
|
|
|
88.17 |
3.36% |
51.15% |
18.09% |
|---|
| EXEL |
Exelixis, Inc. |
10.40B |
0.96% |
|
|
|
|
|
36.43 |
0.64% |
34.72% |
24.39% |
|---|
| ITCI |
Intra-Cellular Therapies, Inc. |
13.44B |
0.89% |
|
|
|
|
|
126.50 |
0.24% |
12.02% |
5.91% |
|---|
| ROIV |
Roivant Sciences Ltd. |
8.20B |
0.85% |
|
|
|
|
|
11.27 |
1.08% |
36.56% |
51.66% |
|---|
| ASND |
Ascendis Pharma A/S |
7.83B |
0.82% |
|
|
|
|
|
131.06 |
2.29% |
43.19% |
19.53% |
|---|
| BGNE |
BeiGene, Ltd. |
20.21B |
0.80% |
|
|
|
|
|
184.71 |
0.49% |
39.65% |
32.18% |
|---|
| JAZZ |
Jazz Pharmaceuticals plc |
7.34B |
0.75% |
|
|
|
|
|
121.43 |
0.21% |
27.41% |
17.79% |
|---|
| RVMD |
Revolution Medicines, Inc. |
7.32B |
0.74% |
|
|
|
|
|
40.16 |
-0.32% |
41.57% |
26.44% |
|---|
| MDGL |
Madrigal Pharmaceuticals, Inc. |
6.70B |
0.68% |
|
|
|
|
|
307.08 |
4.58% |
60.53% |
13.64% |
|---|
| HALO |
Halozyme Therapeutics, Inc. |
7.12B |
0.61% |
|
|
|
|
|
55.94 |
2.08% |
36.82% |
16.72% |
|---|
| BPMC |
Blueprint Medicines Corporation |
7.11B |
0.56% |
|
|
|
|
|
111.96 |
1.74% |
71.64% |
50.84% |
|---|
| IONS |
Ionis Pharmaceuticals, Inc. |
5.16B |
0.56% |
|
|
|
|
|
32.68 |
3.98% |
47.94% |
47.62% |
|---|
| CYTK |
Cytokinetics, Incorporated |
5.41B |
0.55% |
|
|
|
|
|
45.82 |
0.17% |
49.96% |
24.11% |
|---|
| TEM |
Tempus AI Inc |
|
0.53% |
|
|
|
|
|
|
|
|
|
|---|
| BBIO |
BridgeBio Pharma, Inc. |
6.82B |
0.53% |
|
|
|
|
|
36.08 |
6.78% |
56.60% |
14.84% |
|---|
| NUVL |
Nuvalent, Inc. |
5.56B |
0.52% |
|
|
|
|
|
78.28 |
3.22% |
36.65% |
27.13% |
|---|
| CRNX |
Crinetics Pharmaceuticals, Inc. |
3.59B |
0.48% |
|
|
|
|
|
38.76 |
3.78% |
56.55% |
40.68% |
|---|
| ALKS |
Alkermes plc |
4.87B |
0.47% |
|
|
|
|
|
30.10 |
2.14% |
46.26% |
68.15% |
|---|
| KRYS |
Krystal Biotech, Inc. |
4.36B |
0.45% |
|
|
|
|
|
151.55 |
2.13% |
46.30% |
38.47% |
|---|
| ACLX |
Arcellx, Inc. |
3.60B |
0.42% |
|
|
|
|
|
66.57 |
0.14% |
43.95% |
20.66% |
|---|
| AXSM |
Axsome Therapeutics, Inc. |
4.66B |
0.42% |
|
|
|
|
|
96.18 |
4.62% |
44.47% |
15.98% |
|---|
| SRRK |
Scholar Rock Holding Corporation |
4.20B |
0.41% |
|
|
|
|
|
44.88 |
4.06% |
53.95% |
2.06% |
|---|
| ADMA |
ADMA Biologics, Inc. |
3.82B |
0.41% |
|
|
|
|
|
16.16 |
0.87% |
54.56% |
9.05% |
|---|
| APLS |
Apellis Pharmaceuticals, Inc. |
3.75B |
0.40% |
|
|
|
|
|
30.13 |
0.65% |
48.52% |
6.08% |
|---|
| RARE |
Ultragenyx Pharmaceutical Inc. |
3.81B |
0.40% |
|
|
|
|
|
41.28 |
3.20% |
76.41% |
39.63% |
|---|
| GH |
Guardant Health, Inc. |
5.58B |
0.37% |
|
|
|
|
|
45.13 |
23.10% |
59.19% |
18.75% |
|---|
| IMVT |
Immunovant, Inc. |
3.46B |
0.36% |
|
|
|
|
|
23.59 |
-1.13% |
72.35% |
51.64% |
|---|
| RNA |
Avidity Biosciences, Inc. |
3.68B |
0.36% |
|
|
|
|
|
30.84 |
6.64% |
84.48% |
21.79% |
|---|
| PTCT |
PTC Therapeutics, Inc. |
3.49B |
0.35% |
|
|
|
|
|
45.25 |
3.22% |
59.40% |
28.98% |
|---|
| CRSP |
CRISPR Therapeutics AG |
3.54B |
0.34% |
|
|
|
|
|
41.51 |
2.42% |
58.04% |
23.81% |
|---|
| RYTM |
Rhythm Pharmaceuticals, Inc. |
3.54B |
0.34% |
|
|
|
|
|
57.52 |
5.46% |
49.64% |
28.71% |
|---|
| VRNA |
Verona Pharma plc |
4.38B |
0.34% |
|
|
|
|
|
53.50 |
3.10% |
63.22% |
8.99% |
|---|
| ALVO |
Alvotech |
4.03B |
0.34% |
|
|
|
|
|
13.36 |
0.68% |
N/A |
N/A |
|---|
| NVCR |
NovoCure Limited |
2.92B |
0.33% |
|
|
|
|
|
26.96 |
3.02% |
51.49% |
-1.13% |
|---|
| VCYT |
Veracyte, Inc. |
3.38B |
0.31% |
|
|
|
|
|
43.60 |
7.44% |
65.09% |
8.64% |
|---|
| DNLI |
Denali Therapeutics Inc. |
3.32B |
0.29% |
|
|
|
|
|
23.04 |
5.06% |
123.33% |
4.46% |
|---|
| XENE |
Xenon Pharmaceuticals Inc. |
2.97B |
0.29% |
|
|
|
|
|
38.98 |
1.19% |
60.53% |
44.44% |
|---|
| MRUS |
Merus N.V. |
2.72B |
0.29% |
|
|
|
|
|
39.74 |
0.74% |
59.54% |
17.10% |
|---|
| FOLD |
Amicus Therapeutics, Inc. |
2.84B |
0.29% |
|
|
|
|
|
9.51 |
1.06% |
41.77% |
54.24% |
|---|
| TWST |
Twist Bioscience Corporation |
3.01B |
0.28% |
|
|
|
|
|
50.45 |
6.08% |
78.88% |
50.28% |
|---|
| JANX |
Janux Therapeutics, Inc. |
2.36B |
0.28% |
|
|
|
|
|
40.91 |
0.47% |
122.42% |
22.60% |
|---|
| VCEL |
Vericel Corporation |
2.94B |
0.28% |
|
|
|
|
|
59.56 |
0.83% |
46.83% |
16.57% |
|---|
| ACAD |
ACADIA Pharmaceuticals Inc. |
2.98B |
0.28% |
|
|
|
|
|
17.89 |
1.82% |
41.92% |
23.75% |
|---|
| RXRX |
Recursion Pharmaceuticals, Inc. |
2.64B |
0.28% |
|
|
|
|
|
6.88 |
5.36% |
87.21% |
23.36% |
|---|
| EWTX |
Edgewise Therapeutics, Inc. |
2.59B |
0.27% |
|
|
|
|
|
27.39 |
4.30% |
97.34% |
21.37% |
|---|
| SWTX |
SpringWorks Therapeutics, Inc. |
2.70B |
0.27% |
|
|
|
|
|
36.35 |
4.97% |
125.21% |
62.97% |
|---|
| LEGN |
Legend Biotech Corporation |
6.36B |
0.26% |
|
|
|
|
|
34.67 |
6.15% |
67.19% |
31.66% |
|---|
| VERA |
Vera Therapeutics, Inc. |
2.13B |
0.26% |
|
|
|
|
|
33.70 |
0.99% |
64.59% |
51.85% |
|---|
| KYMR |
Kymera Therapeutics, Inc. |
2.83B |
0.26% |
|
|
|
|
|
43.70 |
7.61% |
68.52% |
33.05% |
|---|
| AMRX |
Amneal Pharmaceuticals, Inc. |
3.95B |
0.24% |
|
|
|
|
|
8.56 |
3.63% |
182.91% |
18.97% |
|---|
| DYN |
Dyne Therapeutics, Inc. |
1.48B |
0.24% |
|
|
|
|
|
14.55 |
2.97% |
73.66% |
13.75% |
|---|
| NAMS |
NewAmsterdam Pharma Company N.V. |
2.53B |
0.24% |
|
|
|
|
|
23.70 |
0.64% |
69.51% |
8.83% |
|---|
| ARWR |
Arrowhead Pharmaceuticals, Inc. |
2.46B |
0.23% |
|
|
|
|
|
19.76 |
1.02% |
48.52% |
33.92% |
|---|
| PTGX |
Protagonist Therapeutics, Inc. |
2.27B |
0.23% |
|
|
|
|
|
38.10 |
3.48% |
81.06% |
55.70% |
|---|
| IOVA |
Iovance Biotherapeutics, Inc. |
1.79B |
0.22% |
|
|
|
|
|
5.88 |
-0.51% |
36.66% |
17.90% |
|---|
| BEAM |
Beam Therapeutics Inc. |
2.03B |
0.22% |
|
|
|
|
|
24.53 |
4.65% |
77.41% |
64.63% |
|---|
| IDYA |
IDEAYA Biosciences, Inc. |
2.00B |
0.22% |
|
|
|
|
|
23.15 |
4.37% |
119.12% |
6.91% |
|---|
| TARS |
Tarsus Pharmaceuticals, Inc. |
1.79B |
0.21% |
|
|
|
|
|
46.74 |
0.47% |
82.26% |
27.51% |
|---|
| LGND |
Ligand Pharmaceuticals Incorporated |
2.22B |
0.21% |
|
|
|
|
|
117.36 |
4.89% |
51.24% |
47.66% |
|---|
| APGE |
Apogee Therapeutics, Inc. |
2.31B |
0.20% |
|
|
|
|
|
39.46 |
6.48% |
62.60% |
81.06% |
|---|
| SUPN |
Supernus Pharmaceuticals, Inc. |
2.13B |
0.20% |
|
|
|
|
|
38.58 |
2.23% |
46.15% |
46.09% |
|---|
| CGON |
CG Oncology, Inc. Common stock |
2.28B |
0.20% |
|
|
|
|
|
30.00 |
3.16% |
70.32% |
2.71% |
|---|
| GERN |
Geron Corporation |
1.79B |
0.20% |
|
|
|
|
|
2.9600 |
2.42% |
149.94% |
16.47% |
|---|
| MIRM |
Mirum Pharmaceuticals, Inc. |
2.30B |
0.20% |
|
|
|
|
|
47.98 |
2.19% |
48.59% |
25.44% |
|---|
| AKRO |
Akero Therapeutics, Inc. |
1.79B |
0.20% |
|
|
|
|
|
25.60 |
1.83% |
244.65% |
88.91% |
|---|
| WVE |
Wave Life Sciences Ltd. |
1.69B |
0.20% |
|
|
|
|
|
11.10 |
1.00% |
90.42% |
7.01% |
|---|
| HRMY |
Harmony Biosciences Holdings, Inc. |
2.31B |
0.19% |
|
|
|
|
|
40.46 |
3.61% |
67.35% |
53.67% |
|---|
| IBRX |
ImmunityBio, Inc. |
2.35B |
0.19% |
|
|
|
|
|
3.22 |
9.52% |
193.35% |
35.33% |
|---|
| AGIO |
Agios Pharmaceuticals, Inc. |
1.90B |
0.19% |
|
|
|
|
|
33.23 |
2.50% |
62.21% |
55.32% |
|---|
| IRON |
Disc Medicine, Inc. |
1.80B |
0.19% |
|
|
|
|
|
60.52 |
3.91% |
57.60% |
13.65% |
|---|
| MNKD |
MannKind Corporation |
1.67B |
0.19% |
|
|
|
|
|
6.04 |
0.50% |
108.16% |
19.64% |
|---|
| NMRA |
Neumora Therapeutics, Inc. Common Stock |
332.82M |
0.18% |
|
|
|
|
|
2.0600 |
0.49% |
80.17% |
12.95% |
|---|
| AMPH |
Amphastar Pharmaceuticals, Inc. |
1.73B |
0.18% |
|
|
|
|
|
36.03 |
0.92% |
46.25% |
26.50% |
|---|
| FTRE |
Fortrea Holdings Inc. |
1.68B |
0.17% |
|
|
|
|
|
18.70 |
5.71% |
63.82% |
37.46% |
|---|
| GPCR |
Structure Therapeutics Inc. |
1.62B |
0.17% |
|
|
|
|
|
28.34 |
4.73% |
73.68% |
6.40% |
|---|
| DVAX |
Dynavax Technologies Corporation |
1.67B |
0.17% |
|
|
|
|
|
12.68 |
1.85% |
37.49% |
47.59% |
|---|
| INDV |
Indivior PLC |
1.52B |
0.17% |
|
|
|
|
|
12.23 |
4.98% |
85.95% |
40.17% |
|---|
| ARQT |
Arcutis Biotherapeutics, Inc. |
1.53B |
0.17% |
|
|
|
|
|
13.08 |
3.15% |
295.06% |
45.26% |
|---|